Systemic Anti-Cancer Therapy Regimen Library New Zealand Formulary

Skin Cancer Regimens

Basal cell Regimens

Published Sort regimens by
SKIN BCC Metastatic - vismodegib Id: 57441000210102 Published date: Version: 3.0.0
57441000210102
3.0.0
29/06/2025

Melanoma Regimens

Published Sort regimens by
SKIN Melanoma Metastatic - biNIMEtinib and encorafenib Id: 57401000210100 Published date: Version: 2.0.0
57401000210100
2.0.0
29/06/2025
SKIN Melanoma Metastatic - cARBOplatin, PACLItaxel, and beVACizumab Id: 57451000210104 Published date: Version: 4.0.0
57451000210104
4.0.0
13/08/2023
SKIN Melanoma Metastatic - cOBIMEtinib and vemurafenib Id: 57461000210101 Published date: Version: 2.0.0
57461000210101
2.0.0
29/06/2025
SKIN Melanoma Metastatic - daBRAFEnib and tRAMEtinib Id: 58931000210101 Published date: Version: 2.0.0
58931000210101
2.0.0
05/07/2022
SKIN Melanoma Metastatic - dacarbazine Id: 57471000210107 Published date: Version: 3.0.0
57471000210107
3.0.0
08/05/2026
SKIN Melanoma Metastatic - imatinib Id: 57481000210109 Published date: Version: 3.0.0
57481000210109
3.0.0
29/06/2025
SKIN Melanoma Metastatic - ipilimumab 1mg/kg and nivolumab 3mg/kg Id: 57491000210106 Published date: Version: 1.0.0
57491000210106
1.0.0
30/09/2021
SKIN Melanoma Metastatic - [for brain metastasis] ipilimumab 3mg/kg and nivolumab 1mg/kg Id: 57501000210101 Published date: Version: 1.0.0
57501000210101
1.0.0
02/08/2024
SKIN Melanoma Metastatic - ipilimumab and pembrolizumab Id: 57511000210104 Published date: Version: 1.0.0
57511000210104
1.0.0
30/09/2021
SKIN Melanoma Metastatic - nivolumab Q2W [flat dosing] Id: 57521000210109 Published date: Version: 1.0.0
57521000210109
1.0.0
30/09/2021
SKIN Melanoma Metastatic - nivolumab Q2W [weight based dosing] Id: 57531000210106 Published date: Version: 1.0.0
57531000210106
1.0.0
30/09/2021
SKIN Melanoma Metastatic - nivolumab Q4W [flat dosing] Id: 57541000210103 Published date: Version: 1.0.0
57541000210103
1.0.0
30/09/2021
SKIN Melanoma Metastatic - pembrolizumab Q3W [flat dosing] Id: 57551000210100 Published date: Version: 1.0.0
57551000210100
1.0.0
30/09/2021
SKIN Melanoma Metastatic - pembrolizumab Q3W [weight based dosing] Id: 57561000210102 Published date: Version: 1.0.0
57561000210102
1.0.0
30/09/2021
SKIN Melanoma Metastatic - pembrolizumab Q6W [flat dosing] Id: 57571000210108 Published date: Version: 2.0.0
57571000210108
2.0.0
26/02/2026
SKIN Melanoma Neoadjuvant - ipilimumab [flat dosing] Q3W and nivolumab [flat dosing] Q3W Id: 506521000210102 Published date: Version: 1.0.0
506521000210102
1.0.0
05/08/2025
SKIN Melanoma NON-Metastatic - daBRAFEnib and tRAMEtinib Id: 59021000210108 Published date: Version: 2.0.0
59021000210108
2.0.0
05/07/2022
SKIN Melanoma NON-Metastatic - nivolumab Q2W [flat dosing] Id: 57581000210105 Published date: Version: 1.0.0
57581000210105
1.0.0
30/09/2021
SKIN Melanoma NON-Metastatic - nivolumab Q2W [weight based dosing] Id: 57591000210107 Published date: Version: 1.0.0
57591000210107
1.0.0
30/09/2021
SKIN Melanoma NON-Metastatic - nivolumab Q4W [flat dosing] Id: 57601000210102 Published date: Version: 1.0.0
57601000210102
1.0.0
30/09/2021
SKIN Melanoma NON-Metastatic - pembrolizumab Q3W [flat dosing] Id: 57611000210100 Published date: Version: 1.0.0
57611000210100
1.0.0
30/09/2021
SKIN Melanoma NON-Metastatic - pembrolizumab Q3W [weight based dosing] Id: 57621000210105 Published date: Version: 1.0.0
57621000210105
1.0.0
30/09/2021
SKIN Melanoma NON-Metastatic - pembrolizumab Q6W [flat dosing] Id: 57631000210107 Published date: Version: 2.0.0
57631000210107
2.0.0
26/02/2026

Merkel cell Regimens

Published Sort regimens by
SKIN MCC Metastatic - cARBOplatin and etoposide Id: 393211000210101 Published date: Version: 1.0.0
393211000210101
1.0.0
18/08/2024
SKIN MCC Metastatic - cARBOplatin and oral etoposide Id: 393201000210103 Published date: Version: 1.0.0
393201000210103
1.0.0
18/08/2024
SKIN MCC Metastatic - pembrolizumab Q3W [flat dosing] Id: 57431000210105 Published date: Version: 1.0.0
57431000210105
1.0.0
30/09/2021
SKIN MCC Metastatic - pembrolizumab Q3W [weight based dosing] Id: 57421000210108 Published date: Version: 1.0.0
57421000210108
1.0.0
30/09/2021
SKIN MCC Metastatic - pembrolizumab Q6W [flat dosing] Id: 57411000210103 Published date: Version: 2.0.0
57411000210103
2.0.0
26/02/2026

Squamous cell Regimens

Published Sort regimens by
SKIN SQCC Metastatic - cARBOplatin and PACLItaxel Id: 393271000210105 Published date: Version: 1.0.0
393271000210105
1.0.0
18/08/2024
SKIN SQCC Metastatic - cemiplimab Id: 393651000210100 Published date: Version: 1.0.0
393651000210100
1.0.0
18/09/2024
SKIN SQCC Metastatic - pembrolizumab Q3W [flat dosing] Id: 57641000210104 Published date: Version: 1.0.0
57641000210104
1.0.0
30/09/2021
SKIN SQCC Metastatic - pembrolizumab Q3W [weight based dosing] Id: 57651000210101 Published date: Version: 1.0.0
57651000210101
1.0.0
30/09/2021
SKIN SQCC Metastatic - pembrolizumab Q6W [flat dosing] Id: 57661000210103 Published date: Version: 2.0.0
57661000210103
2.0.0
26/02/2026
SKIN SQCC Neoadjuvant - cemiplimab Id: 393641000210103 Published date: Version: 1.0.0
393641000210103
1.0.0
18/09/2024